Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 04.04.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
04.04.Oncopeptides AB: Oncopeptides releases first quarter 2024 sales45Stockholm - April 4, 2024 - Oncopeptides AB (STO: ONCO), a biotech company focused on difficult-to-treat cancers, today announces the unaudited net sales for the first quarter of 2024. Oncopeptides...
► Artikel lesen
04.04.Gorilla Technology Group Inc.: Gorilla Reports Record 2023 Financial Results50LONDON, April 04, 2024 (GLOBE NEWSWIRE) -- -- 2023 revenues up 189% YoY compared to 2022, highlighting continued success globally ---- High value product and services business model reflected in 2023...
► Artikel lesen
04.04.Olaplex Holdings, Inc.: OLAPLEX Announces CFO Transition534SANTA BARBARA, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or "the Company") today announced that Eric Tiziani will step down as Chief Financial Officer...
► Artikel lesen
04.04.Teck Resources Ltd: Teck Provides Steelmaking Coal Sales and Pricing Update185VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) ("Teck") today provided unaudited first quarter 2024 steelmaking coal sales...
► Artikel lesen
04.04.Semantix, Inc.: Semantix Announces Voluntary Delisting from the Nasdaq Global Market314SÃO PAULO, Brazil, April 04, 2024 (GLOBE NEWSWIRE) -- Semantix, Inc. (NASDAQ: STIX) ("Semantix" or the "Company"), a leading Latin American enterprise AI platform and applications provider, announced...
► Artikel lesen
04.04.Mersana Therapeutics, Inc.: Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)81CAMBRIDGE, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug...
► Artikel lesen
04.04.Trisura Group Ltd: Trisura Group Announces Changes to its Board of Directors82TORONTO, April 04, 2024 (GLOBE NEWSWIRE) -- Trisura Group Ltd. ("Trisura" or "Trisura Group") (TSX: TSU) today announced the appointment of Lilia Sham to its Board of Directors and the retirement...
► Artikel lesen
04.04.Keyarch Acquisition Corp.: ZOOZ Power Ltd. Ordinary Shares and Public Warrants to Trade on Nasdaq on April 5, 2024, as the Business Combination between Keyarch Acquisition Corporation and ZOOZ Power Ltd. Has Been Completed77ZOOZ Power Ltd. Ordinary Shares and Public Warrants to Trade on Nasdaq under the Symbols "ZOOZ" and "ZOOZW," respectively NEW YORK, NY, April 04, 2024 (GLOBE NEWSWIRE) -- Keyarch Acquisition Corporation...
► Artikel lesen
04.04.GENFIT S.A.: GENFIT Reports Full-Year 2023 Financial Results and Provides Corporate Update139Cash and cash equivalents totaled €77.8 million as of December 31, 2023Revenues amounted to €28.6 million as of December 31, 2023 including a milestone payment of €13.3 millionTopline interim data...
► Artikel lesen
04.04.Amwell Receives Continued Listing Standard Notice From NYSE65Boston, April 04, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of healthcare software as a service, today announced that it received a notice on April 2, 2024 from the New York...
► Artikel lesen
04.04.Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of VISTA within the Tumor Microenvironment111BOSTON, April 04, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics...
► Artikel lesen
04.04.Vimeo, Inc.: Vimeo Appoints Philip Moyer as New Chief Executive Officer95NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Vimeo (NASDAQ: VMEO), the leading video platform for businesses, today announced the appointment of Philip Moyer as Chief Executive Officer and member...
► Artikel lesen
04.04.Apellis Pharmaceuticals, Inc.: Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)121WALTHAM, Mass., April 04, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company approved the grant of equity awards to one new employee with a grant...
► Artikel lesen
04.04.Kura Sushi USA Announces Fiscal Second Quarter 2024 Financial Results154IRVINE, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- Kura Sushi USA, Inc. ("Kura Sushi" or the "Company") (NASDAQ: KRUS), a technology-enabled Japanese restaurant concept, today announced financial...
► Artikel lesen
04.04.Grindrod Shipping Holdings Ltd. Announces Proposed Selective Capital Reduction157SINGAPORE, April 04, 2024 (GLOBE NEWSWIRE) -- Exhibit 99.1 GRINDROD SHIPPING HOLDINGS LTD.(Incorporated in Singapore)(Registration No.: 201731497H)Primary listing on the NASDAQ Global Select MarketSecondary...
► Artikel lesen
04.04.Invivyd Provides PEMGARDA Launch Update and Announces 2024 Net Product Revenue Guidance in the Range of $150 Million to $200 Million124PEMGARDA now commercially available in the U.S. for pre-exposure prophylaxis (PrEP) of COVID-19 in certain adults and adolescents with moderate-to-severe immune compromise Based on anticipated net...
► Artikel lesen
04.04.Conifer Holdings, Inc.: Conifer Holdings Reports 2023 Fourth Quarter and Year End Financial Results; Announces Strategic Shift to Production Based Revenue56TROY, Mich., April 04, 2024 (GLOBE NEWSWIRE) -- Conifer Holdings, Inc. (Nasdaq: CNFR) ("Conifer" or the "Company") today announced results for the fourth quarter and year ended December 31, 2023....
► Artikel lesen
04.04.Mural Oncology, Inc.: Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)92WALTHAM, Mass. and DUBLIN, Ireland, April 04, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company leveraging its core competencies in immune cell modulation...
► Artikel lesen
04.04.Caribou Biosciences, Inc.: Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus98-- FDA has cleared Caribou's IND application for CB-010 in lupus nephritis and extrarenal lupus; GALLOP Phase 1 clinical trial expected to initiate by YE 2024 -- -- Driven by encouraging initial safety...
► Artikel lesen
04.04.Lithium Ionic Corp.: Lithium Ionic Announces Maiden Mineral Resource Estimate and Initiation of PEA at its Salinas Project, Minas Gerais, Brazil; Increases Regional Mineral Resources by 45%65Salinas MRE increases global resources by 45% to 47.8Mt M&I: 5.86Mt @ 1.09% Li2OInferred 8.9Mt @ 0.97% Li2O~65% of the MRE is considered open pit PEA for Salinas initiated; completion expected in...
► Artikel lesen
Seite:  Weiter >>